Oliver McCammon
Analyst
Lifeside Capital
Equibles does not estimate personal net worth.
About Oliver McCammon
Oliver McCammon is recorded as Analyst at Lifeside Capital. Oliver McCammon has spoken on 1 investor event across 1 company, most recently for Candel Therapeutics, Inc. on May 15, 2026. The companies whose calls Oliver McCammon spoke on are classified in the Healthcare sector.
Oliver McCammon on recent calls
“For the external experts on the call, we heard some discussion on potentially sparing patients' hormone therapy. Assuming 24-9 is approved, do you think ADT use could shift among the intermediate and high-risk patients electing to receive radiotherapy?”
Affiliation history
-
Lifeside Capital
Analyst
Transcript header (unverified)
Current
Company network
Recent activity
-
Annual General Meeting AUA Annual Meeting - Candel Therapeutics Call Candel Therapeutics, Inc. (CADL)